What Is Type 3 Diabetes? Insulin Resistance In The Brain That Could Trigger Alzheimer’s
Most people are aware of type 1 and type 2 diabetes, but did you know there is a type 3 diabetes as well! It is a more obscure term. Although it is not an accepted medical diagnosis, type 3 diabetes has been discussed in the literature as a possible relationship between insulin resistance in the brain and Alzheimer's disease. This link has been described to help explain how metabolic disorders impact brain health, causing cognitive decline and dementia.
Type 3 diabetes is more of a misnomer because it should not be confused with type 3c diabetes, which relates to pancreatic dysfunction. The term "type 3 diabetes," on the other hand, has been loosely used by some scientists to analogously propose that Alzheimer's disease is strongly implicated with insulin resistance in the brain.
This concept was conceptualized by Dr. Suzanne de la Monte and Dr. Jack Wands of Brown University in the year 2008. This hypothesis postulated that Alzheimer's disease may be called type 3 diabetes for it bears many similarities with glucose metabolism disorder type 2 diabetes. Their concept arises from the basic principle that insulin is fundamental to blood sugar regulation, but it is also the case with the brain. When brain cells become insulin-resistant, they lose access to glucose, impairing their function.
Research published in the Journal of Diabetes Science and Technology supports this hypothesis by indicating that insulin resistance can be a significant contributor to the occurrence of dementia, also referred to as Alzheimer's. The symptoms of memory loss and diminished reasoning are associated with impaired glucose metabolism in the body, especially in the cerebral tissue.
Although type 3 diabetes is not a "medical term," its symptoms correlate well with Alzheimer's diseases that are known to reduce the ability to think in an efficient manner and bring down brain health. These signs are:
- Loss of memory, especially short-term.
- Poor judgment and judgment ability
- Failure in recognizing people or places familiar once.
- Failure in the process of reading, writing or processing numbers
- Anxiety, agitation, or mood changes.
- Disorganized thoughts or confusion
- Lack of impulse control
As the disease advances, patients may be afflicted with severe complications including an inability to swallow or control their bodily functions. In the final stages, most patients die from fatal complications such as aspiration pneumonia.
This may not be well understood with regards to type 3 diabetes, or the exact link between insulin resistance and Alzheimer's disease. Some identified contributing factors include the following:
Insulin acts as an important regulatory mechanism of brain functions such as memory and cognition. The reduction in insulin signaling may impair metabolism of brain cells, thus bringing about neurodegeneration.
These diseases show a strong relationship and those individuals diagnosed with type 2 diabetes have double chances of getting Alzheimer's. In the two, the main causes can be chronic inflammation, oxidative stress, and a defect in glucose metabolism.
Insulin resistance associated with obesity, stress, and an unhealthy diet is considered a cause that may increase the chances of Alzheimer's disease.
Researches in Frontiers in Neuroscience and The Lancet Neurology have also highlighted that drugs used for antidiabetic medication may be crucial for the prevention or at least slowing down the course of Alzheimer's.
In 2022, in a study in Pharmaceuticals, researchers studied biomarker uptake in brain regions implicated in the faulty uptake and metabolism of blood sugar in Alzheimer’s patients.
Emerging Therapies
Research into such treatments as intranasal insulin has also been promising. Intranasal delivery of insulin directly to the brain has been reported to enhance glucose uptake by brain cells, improve memory, and boost cognitive performance. While such clinical trials have been shown to be successful, additional research is needed for safety and efficacy.
Medications
For patients being aggressive or agitated, antipsychotic drugs may be prescribed; however, therapies such as cognitive rehabilitation as well as cognitive stimulation therapy serve to preserve memory and executive function.
Lifestyle Interventions
Diet, exercise, and stress management are critical in preventing and managing insulin resistance. A review in the Journal of Alzheimer's Disease also highlighted the benefits of Kirtan Kriya meditation, which can regulate genes involved in insulin and glucose metabolism, improve sleep, and reduce inflammation.
Although type 3 diabetes is not officially recognized, its connection to Alzheimer’s disease underscores the importance of proactive measures for brain health. Some prevention strategies include:
1. Healthy Diet
Consuming a balanced diet rich in antioxidants, whole grains, and healthy fats may support brain health.
2. Regular Exercise
Physical activity improves insulin sensitivity, reduces inflammation, and enhances overall metabolic health.
3. Stress Reduction
Mindfulness practices, including meditation, have been shown to lower stress levels, which can reduce the risk of cognitive decline.
The term type 3 diabetes brings out the complex relationship between metabolic disorders and brain health. Even though it is not a recognized medical condition, the concept emphasizes the crucial role of insulin in brain function and its possible contribution to Alzheimer's disease. Continued research will hopefully provide hope for therapies such as intranasal insulin and lifestyle modifications.
Credit: iStock
Headaches are one of the most common health complaints and are often caused by stress, lack of sleep, dehydration, excessive screen time, skipped meals, or other lifestyle factors. While most headaches are benign, experts said that frequent or unusual headaches should not be ignored, as they may signal an underlying medical condition that requires evaluation.
The experts told HealthandMe that paying attention to changes in headache frequency, pattern, and associated symptoms can help identify when medical attention is necessary.
According to Dr. Rajneesh Kummar, Vice Chairman & Unit Head, Neurology, Max Super Speciality Hospital, Dwarka, one of the most common concerns is increasing frequency.
“If someone who previously experienced occasional headaches starts getting them several times a week or finds that painkillers are needed more often than before, it is worth getting evaluated,” he told HealthandMe.
“People should seek medical attention if they have headaches more than 10 to 15 days a month, if the headaches are getting worse, or if they are beginning to interfere with work, daily activities, or quality of life,” added Dr. Praveen Gupta, Chairman, MAIINS, Marengo Asia Hospitals, Gurugram. He also noted that medication-overuse headaches can result from taking painkillers regularly, leading to a cycle of recurrent pain.
Also read: Shingles Vaccine May Help Fight Dementia, Suggest Studies
A change in the pattern of headaches should not be ignored. Dr. Kummar said a headache that feels different from what a person has experienced in the past, particularly after the age of 50, deserves medical attention. Headaches that wake a person from sleep, are worse in the early morning, or are associated with vomiting should also be assessed further.
Dr. Gupta advised prompt medical evaluation for people over the age of 50 who develop a new type of headache. He also recommends seeing a doctor if a person has a history of cancer, a weakened immune system, or develops a headache after a head injury.
The neurologists highlight several "red flag" symptoms that require urgent medical assessment. They advised immediate consultation if a headache is accompanied by
Read More:Sepsis: India Joins Global Trial To Screen Newborns For Deadly Drug-Resistant Infections
Dr. Kummar stated that many people worry that every headache is related to a brain tumor or another serious brain disorder. Fortunately, this is rarely the case.
However, persistent or unusual headaches should not be self-diagnosed, and timely consultation helps identify the cause and ensures appropriate treatment before the problem begins affecting quality of life, the expert said.
Dr. Gupta told HealthandMe that early diagnosis can help manage common neurological disorders such as migraines, cluster headaches, and chronic tension-type headaches. A thorough history, neurological examination, and imaging studies, when appropriate, can help determine the cause.
The experts emphasize that if headaches are becoming more frequent, changing in patterns, or affecting daily life, it is time to consult a neurologist. Early diagnosis can provide relief, prevent complications, and improve overall quality of life.
Credit: iStock
Several recent studies suggest that older adults who receive the shingles vaccine may be less likely to develop dementia, a condition affecting more than 57 million people worldwide.
Shingles is a painful viral infection caused by the reactivation of the varicella-zoster virus (VZV), which can remain dormant after chickenpox and later trigger a blistering rash and severe nerve pain.
A June 2026 study published in the Annals of Internal Medicine suggests that one in 17 dementia cases could potentially be prevented through shingles vaccination.
Researchers at Brown University found that older adults who received the recombinant shingles vaccine (Shingrix) after a stay in a skilled nursing facility had a 24% lower risk of being diagnosed with dementia over four years than those who were not vaccinated.
The study analyzed Medicare and health records from more than 500,000 adults aged 66 and older admitted to skilled nursing facilities. Researchers compared those who received at least one dose of Shingrix with those who remained unvaccinated.
“A lot of previous studies with similar results focused on an older vaccine,” said study author Kaley Hayes, an assistant professor at Brown University’s School of Public Health.
“This study looks at the newest vaccine only in an older, vulnerable adult population who were not up to date with shingles vaccination and are at a very clear clinical point in care: entering a skilled nursing facility.”
The findings add to growing evidence linking shingles vaccination with a lower risk of dementia.
Also read: How To Spot Leptospirosis, Dengue, Malaria During Monsoons? Early Symptoms Not To Neglect
Researchers believe the vaccine may help protect the brain by preventing shingles and the inflammation caused by the virus.
Shingles can cause a “war zone” of inflammation in the brain, said Dr. Jennifer Pauldurai, the medical director of the Inova Brain Health and Memory Disorders Program in Northern Virginia, NBC News reported.
It’s not that the shingles vaccine itself is a “magic pill,” Pauldurai said.
Rather, the vaccine guards against the disease, which is known to disrupt brain health.
The latest findings add to a growing body of international research.
A study involving more than 282,000 older adults in Wales, published in Nature in 2025, found shingles vaccination was associated with a 3.5% lower absolute risk of dementia over seven years.
Another study of more than 101,000 older adults in Australia, published in the Journal of the American Medical Association in 2025, found vaccine eligibility was associated with a 1.8% lower dementia risk over 7.4 years.
Similarly, a study involving more than 232,000 older adults in Canada, published in The Lancet Neurology in 2026, linked shingles vaccine eligibility to a 2% lower dementia risk over 5.5 years.
Read More: Sepsis: India Joins Global Trial To Screen Newborns For Deadly Drug-Resistant Infections
After a person recovers from chickenpox, the VZV virus remains dormant in nerve cells and can become active again years or even decades later, particularly when the immune system weakens.
Older adults and people with weakened immune systems are at the highest risk of developing shingles.
According to the NHS, shingles often starts with:
Seek prompt medical attention if:
Credit: iStock
From bone smashing to black market peptides, the modern push to “optimize” the male body increasingly runs through human endocrinology, often without a doctor anywhere in the loop.
Looksmaxxing began on incel forums that blamed romantic failure on fixed facial geometry. That ideology has since spread to TikTok and Instagram, stripped of some of its uglier language but keeping its core premise: a man’s body can and should be engineered, whatever the cost. What started as a fringe belief system now functions as mainstream influencer content with millions of followers.
Clinicians split the practice into softmaxing (sleep, skincare, fitness, mostly harmless) and hardmaxxing, which branches into two wings: mechanical (bone smashing, jaw implants, leg lengthening) and pharmaceutical (unsupervised testosterone, anabolic steroids, SARMs, and peptides marketed as growth hormone substitutes). The pharmaceutical wing is growing fastest, and it sits squarely in endocrinology’s territory.
The body regulates testosterone through a feedback loop running from the hypothalamus to the pituitary to the testes. Flood that system with outside testosterone or anabolic steroids, and it shuts down its own production, taking fertility down with it. SARMs were built to act on muscle and bone while sparing the prostate, but none are approved for human use, and the versions sold online are unregulated and inconsistently dosed. Peptides like ibutamoren (MK-677) stimulate the body’s own growth hormone release. The mechanism sounds gentler, but few have completed real clinical trials for the uses they are marketed for.
● Testicular atrophy and infertility from HPG axis suppression
● Gynecomastia, from testosterone converting to estrogen
● Hepatotoxicity, especially with oral forms
● Psychiatric effects at high doses, including mood instability
● Liver injury, including cholestatic jaundice in black market cases
● Dose-dependent suppression of natural testosterone production
● Elevated liver enzymes, reduced HDL cholesterol
● Elevated hematocrit, raising clotting risk if unmonitored
● Adrenal suppression and disruption of corticosteroid and DHEAS production: exogenous androgens interfere with the hypothalamic-pituitary-adrenal axis, blunting the adrenal gland’s output of cortisol and dehydroepiandrosterone sulphate (DHEAS). The result is impaired stress response, fatigue, and hormonal dysregulation that persists well after the substance is stopped.
● Elevated blood pressure and increased cardiac sympathetic drive: anabolic agents raise systolic pressure and heighten sympathetic nervous system activity in the heart, accelerating resting heart rate and increasing myocardial oxygen demand. Over time, this contributes to left ventricular hypertrophy and raises the risk of arrhythmia.
● Unreliable contents: labels rarely match what is actually in the product, and contamination or substitution is common enough that toxicology reports periodically turn up drugs users never intended to take.
Bone smashing has no basis in orthopedic science. Bone remodels under sustained load, not blunt trauma, which produces fractures, hematomas, and sometimes permanent damage. Cosmetic jaw implants and leg lengthening are legitimate procedures in the right clinical context, but carry the same surgical risks, infection, nerve damage, long recovery, without the medical justification that normally accompanies them.
The pharmaceutical track carries its own structural toll: supraphysiological androgen levels accelerate calcification in tendons and menisci, reducing their elasticity and load-bearing capacity. Meniscal and tendon calcinosis increases the risk of tears and joint instability, often in the absence of any acute injury. Athletes who stop using these compounds may find the damage is already done.
A related danger runs alongside both tracks. Some men adopt extreme dieting, dehydration, or fasting protocols purely to sharpen jaw and cheekbone definition before photos. The behavior carries the same physical risks as any restrictive eating disorder, yet it rarely gets recognized or treated as one, since it is framed online as discipline rather than disorder.
Gallup polling found that roughly a quarter of young American men report frequent loneliness, a notably higher rate than young women. Online communities built around appearance fill that gap with something that looks like belonging, even though the content itself runs on comparison and self-criticism.
TikTok’s own data illustrate how fast the trend has moved: searches for bone smashing and related terms ran in the hundreds of thousands per day in early 2026 and climbed into the millions within a month, before the platform restricted the content. Marketing has kept pace too: one UK survey found nearly a third of 16 to 25-year-olds see SARM ads on social media weekly.
TRT for confirmed hypogonadism, diagnosed through repeat morning bloodwork and monitored over time, is genuinely effective medicine. That is a different undertaking entirely from a eugonadal man sourcing hormones or peptides online to chase a feeling, with no diagnosis and no monitoring. The same distinction applies to surgery: a qualified surgeon’s evaluation is not the same as a procedure booked off a forum recommendation.
None of this is an argument against fitness or grooming, and most softmaxxing is harmless. The danger lies in a narrower set of behaviors: fracturing healthy bone, importing unregulated hormones, chasing a standard that keeps moving regardless of what is achieved.
Endocrinologists studying this are not against masculinity or ambition about one’s appearance. They are arguing that hormonal systems deserve the same evidence-based caution as any other organ system, and that distinction matters more now that these behaviors are still treated as cultural curiosities rather than the clinical concerns they actually are. A blood test and a doctor’s judgment remain better tools than a forum thread and a vial of unknown origin.
© 2024 Bennett, Coleman & Company Limited